|
Dec 13
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
|
|
Dec 11
|
McKesson (MCK) Announces Availability of FDA-Approved Drug
|
|
Dec 10
|
15 Least Competitive Medical Specialties in America
|
|
Dec 4
|
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
|
|
Dec 4
|
McKesson (MCK) Announces Availability of FDA-Cleared Drug
|
|
Dec 1
|
McKesson (MCK) Up 5.1% Since Last Earnings Report: Can It Continue?
|
|
Nov 29
|
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 46%?
|
|
Nov 26
|
15 Best Drug Stocks To Invest In
|
|
Nov 7
|
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
|
|
Nov 6
|
EVP & Chief HR Officer Leann Smith Sells 660 Shares of McKesson Corp
|
|
Nov 6
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
|
Nov 4
|
The McKesson Corp (MCK) Company: A Short SWOT Analysis
|
|
Nov 3
|
Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand
|
|
Nov 2
|
McKesson Corporation (NYSE:MCK) Q2 2024 Earnings Call Transcript
|
|
Nov 2
|
McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View
|
|
Nov 2
|
Dow Jones Futures Rise: Market Rally Gains Steam On Fed Chief Powell's 'Decay'; Palantir Jumps
|
|
Nov 2
|
Q2 2024 Mckesson Corp Earnings Call
|
|
Nov 2
|
Cencora beats quarterly profit estimates on specialty drug demand
|
|
Nov 2
|
McKesson (MCK) Q2 2024 Earnings Call Transcript
|
|
Nov 1
|
Here's What Key Metrics Tell Us About McKesson (MCK) Q2 Earnings
|